# A nurse is teaching a 68-year-old client with atrial fibrillation about bridge anticoagulation in preparation for an elective laparoscopic cholecystectomy in 7 days. The client has been taking warfarin 5 mg daily with INR 2.4 and a CHA2DS2-VASc score of 4. Which teaching points are essential for safe peri-procedural management? Select all that apply. > source: MyMerci (mymerci.kr) > url: https://mymerci.kr/pages/nclex_q.php?qn_id=368103&lang=en > language: en > subject: Adverse Effects/Contraindications/Interactions > category: PPT ## Question A nurse is teaching a 68-year-old client with atrial fibrillation about bridge anticoagulation in preparation for an elective laparoscopic cholecystectomy in 7 days. The client has been taking warfarin 5 mg daily with INR 2.4 and a CHA2DS2-VASc score of 4. Which teaching points are essential for safe peri-procedural management? Select all that apply. 1 Stop warfarin 5 days before surgery to allow INR to drift below 1.5 by the day of surgery 2 Take a single dose of vitamin K 10 mg IV the morning of surgery to ensure rapid INR normalization 3 Begin therapeutic enoxaparin (LMWH) 36 hours after the last warfarin dose, with the last LMWH dose at least 24 hours before surgery 4 Replace warfarin permanently with aspirin 325 mg daily because the laparoscopic procedure is low risk 5 Resume warfarin on the evening of the day of surgery if hemostasis is adequate, with bridging LMWH continued until INR is therapeutic 6 Continue warfarin without interruption to avoid the risk of stroke, since CHA2DS2-VASc is greater than 2 ## Explanation Bridge anticoagulation manages the risk of thromboembolism during temporary warfarin interruption for invasive procedures. For a CHA2DS2-VASc of 4 (moderate-to-high stroke risk), an evidence-based bridging plan: (1) stop warfarin 5 days pre-op so INR drifts below 1.5; (2) start therapeutic-dose LMWH (enoxaparin 1 mg/kg q12h) 36 hours after the last warfarin dose, last dose at least 24 hours before surgery to allow LMWH clearance; (4) resume warfarin on the evening of surgery and continue bridging LMWH until INR is therapeutic for 2 consecutive days. Continuing warfarin (option 6) creates major bleeding risk during laparoscopic surgery. IV vitamin K 10 mg (option 2) causes warfarin resistance for days. Switching chronic warfarin to aspirin (option 4) is inappropriate without electrophysiology consultation. ## In-depth explanation Bridge Anticoagulation Logic Stroke risk during warfarin hold is greater than the bleeding risk of LMWH bridging, so bridging is offered for moderate-to-high CHA2DS2-VASc. Standard Schedule - Day -5: Stop warfarin - Day -3: Start therapeutic LMWH (36 hours after last warfarin) - Day -1: Last LMWH 24 hours pre-op - Day 0: INR less than 1.5 — surgery - Day 0 PM: Resume warfarin - Day +1 onward: LMWH continues until INR is therapeutic for 2 days Wrong Answers 3: Continuing warfarin into surgery creates bleeding risk. 5: IV vitamin K induces warfarin resistance for days. 6: Switching to aspirin without specialist input is out of scope. NCSBN Theme PPT — Adverse effects, bleeding and coagulation. ## Clinical scenario Scenario 68-year-old, atrial fibrillation, on warfarin 5 mg daily, scheduled for elective lap chole in 7 days. Risk - INR 2.4 - CHA2DS2-VASc 4 (moderate-to-high stroke risk) Plan - Bridge anticoagulation with LMWH - Stop warfarin 5 days pre-op - Therapeutic enoxaparin until 24 hours pre-op - Resume warfarin evening of surgery ## Key concepts - **Bridge anticoagulation** — Strategy of replacing oral anticoagulant (warfarin) with a shorter-acting parenteral anticoagulant (LMWH or UFH) during a peri-procedural period to minimize both thromboembolism and bleeding risk. Indicated for moderate-to-high stroke risk (CHA2DS2-VASc 4 or higher in AF) or recent VTE within 3 months. Not needed for low-risk patients. - **CHA2DS2-VASc** — Stroke risk score in non-valvular atrial fibrillation: CHF (1), HTN (1), Age 75 or older (2), DM (1), Stroke or TIA (2), Vascular disease (1), Age 65 to 74 (1), Female sex (1). Score of 2 or more in men or 3 or more in women indicates chronic anticoagulation. - **LMWH (enoxaparin)** — Low-molecular-weight heparin — predictable pharmacokinetics, no PTT monitoring required. Therapeutic dose 1 mg/kg subcutaneous every 12 hours. Last dose 24 hours before surgery to allow clearance. Anti-Xa monitoring in renal failure or weight extremes. Reversal with protamine (incomplete). ## Related questions - [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=en) - [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=en) - [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=en) - [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en) - [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=en) - [A nurse is monitoring a client receiving a continuous IV heparin infusion for pulmonary em…](https://mymerci.kr/pages/nclex_q.php?qn_id=363988&lang=en) - [A nurse is preparing to initiate a weight-based continuous IV unfractionated heparin infus…](https://mymerci.kr/pages/nclex_q.php?qn_id=364107&lang=en) - [A nurse is providing discharge teaching to a 65-year-old client newly prescribed warfarin …](https://mymerci.kr/pages/nclex_q.php?qn_id=364872&lang=en) ## Read in another language - [en](https://mymerci.kr/pages/nclex_q.php?qn_id=368103&lang=en) - [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=368103&lang=ko) - [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=368103&lang=ja) - [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=368103&lang=zh-tw) - [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=368103&lang=vi) --- More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en) _For study reference only. Always follow current clinical guidelines and your institution’s protocols._